Linezolid Therapy of Vancomycin-Resistant Enterococcus faecium Experimental Endocarditis

We compared the activities of linezolid (25 mg/kg of body weight, administered intraperitoneally every 8 h) and of vancomycin (25 mg/kg of body weight, administered intraperitoneally every 8 h) in a rat model of vanA vancomycin-resistant Enterococcus faecium experimental endocarditis. Results were e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Patel, Robin, Rouse, Mark S., Piper, Kerryl E., Steckelberg, James M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2001
Konular:
Experimental Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC90339/
https://ncbi.nlm.nih.gov/pubmed/11158767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.2.621-623.2001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller